We previously reported the metabolic 15 N labeling of a rat where enrichment ranged from 94% to 74%. We report here an improved labeling strategy which generates 94% 15 N enrichment throughout all tissues of the rat. A high 15 N enrichment of the internal standard is necessary for accurate quantitation, and thus, this approach will allow quantitative mass spectrometry analysis of animal models of disease targeting any tissue.
Introduction
The measurement of ion signals by mass spectrometers is precise and quantitative. Sampling handling and ionization are subject to variations that need to be controlled and measured, and thus the use of internal standards to determine variations and errors is common. In addition, the measurement of relative changes in quantity requires an internal standard for every molecule to be compared. A general approach in quantitative mass spectrometry is to mix a protein sample containing only natural-abundance isotopes with an identical protein sample except the proteins are labeled with heavy stable isotopes (i.e., 2 H, 13 C, 15 N, or 18 O). 1, 2 The relative protein expression is calculated from the ion chromatograms of the labeled and unlabeled peptides. [3] [4] [5] [6] Several strategies have been used to introduce labels into proteins including covalent attachment of stable isotope labeled reporter groups, [7] [8] [9] [10] proteolysis in the presence of 18 O water, [11] [12] [13] and metabolic incorporation of stable isotope labeled amino acids. 1, 2, [7] [8] [9] [14] [15] [16] [17] Compared to in vitro labeling methods, metabolic labeling ensures that every protein is enriched with a heavy stable isotope. Metabolic labeling is routinely performed with cultured cells ranging from bacteria, yeast to mammalian cells, and has been demonstrated in multicellular organisms such as Caenorhabditis elegans and Drosophila melanogaster. 18 Ishihama et al. took a creative approach by using a metabolically labeled 15 N Neuro2A mouse cell line as an internal standard for mouse brain. 19 One drawback to this strategy is that the Neuro2A and brain proteome do not completely overlap. For example, neurons in vivo form synapses, while Neuro2A cultured cells do not. To pursue global quantification of complex mammalian tissues with mass spectrometry, we developed a technique to metabolically label a SpragueDawley rat by feeding it a 15 N enriched protein diet for 44 days starting when the rat was 3 weeks old. 20 We demonstrated that the labeled rat was healthy and phenotypically identical to an unlabeled rat. Using the proteins from the 15 N labeled rat liver as internal standards, we quantified global changes in the liver induced by a sublethal dose of cyclohexamide. 20 The introduction of stable isotope labeling of mammalians (SILAM) that serve as models for human physiology and disease creates an opportunity to study a wide range of diseases that affect tissues and organs. We observed, however, a striking difference in the levels of 15 N enrichment in the various organs of the rat. While the average 15 N enrichment of amino acids in liver proteins was 91%, the average 15 N enrichment in brain was 74%. 20 Although the nitrogen source is the same for all tissues, the amino acid precursor pools are not. Tissues with slower protein turnover rates will take longer for the 15 N labeled amino acids to equilibrate with the normal amino acid precursor pool, which leads to a lower enrichment. Consistent with our measured levels of 15 N enrichment, liver has a very high protein turnover rate, while brain has a very low turnover rate. 21, 22 The disadvantage of low 15 N enrichment is that quantitation becomes less efficient and accurate.
In this report, we describe a method to more efficiently feed animals a 15 N labeled protein diet and an improved metabolic labeling strategy to obtain high 15 N protein enrichment of rat brain tissue. We designed and tested two different labeling protocols to determine the optimal procedure to ensure high 15 N enrichment of brain. Furthermore, we show that 15 N labeling of two generations of rats does not interfere with fetal development during gestation. In addition, we report that this protocol is also applicable to other slow protein turnover tissues besides the brain. This method allows quantitative mass spectrometry analysis of animal models of neurological disorders or other types of diseases.
Materials and Methods

Materials.
15 N-Enriched (>99 atom % excess; ape) and unlabeled algal cells were purchased from Spectra Gases (Vista, CA). Digestion enzymes were purchased from Roche Applied Science (Indianapolis, IN). All Sprague-Dawley rats were purchased from Harlan (Indianapolis, IN). All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise noted. All methods involving animals were approved by the Institutional Animal Research Committee and were accredited by the American Association for Accreditation of Laboratory Animal Care.
Preparation of 15 N Enriched Diet. Ten grams of spirulina biomass (algae), unlabeled or 15 N labeled, was mixed well with 30 g protein-free diet powder (Harlan TD 93328). Initially, rats were fed the powder mixture directly; however, we found this method to be a cumbersome and inefficient protocol to feed the rats. To improve our feeding protocol, we created 15 N enriched food pellets. To make the pellets, we sprinkled 6 mL (for unlabeled) or 6.5 mL (for 15 N labeled) of H2O in the powdered food, stirred, and worked the mixture into a dough. The dough was shaped into a long cylinder about 2-cm thick. The cylinder was cut into 2-cm pieces lengthwise. The pellets were dried at 60°C for 2-4 h and then at 35°C overnight using an Excalibur food dehydrator.
Metabolic Labeling with 15 N-Labeled Algal Cells. Protocol 1. Two female Sprague-Dawley rats were delivered to the animal facility on pregnancy day 2. One rat was immediately fed a specialized diet consisting of a protein-free rodent diet (Harlan Teklad, TD93328) supplemented with algal cells containing only natural abundance isotopes (control diet), and the other rat was immediately placed on the 15 N diet.
Protocol 2. Four female rats (littermates) arrived at the animal facility immediately after weaning. Two rats were immediately placed on the 15 N diet and were housed in the same cage. The other two were placed on the control diet and were housed in the same cage. Once the female rats reached sexual maturity, one male rat was placed in the female cage from 6 p.m. to 6 a.m. until pregnancy, which was determined by the observation of a vaginal plug. Before pregnancy, the female rats were offered the 15 N diet or the control diet in powder form for 45 min every 6 h (6 a.m., 12 p.m., 6 p.m., and 12 a.m.). The male rats were removed from the cage when the female rats were given the powdered food. The male rats were given standard Harlan rodent diet ad libitum when caged separately from the female rats.
For both protocols, pregnant female rats were caged separately and the food (in the form of dry pellets) was given to the rats ad libitum. After weaning, the pups were given food ad libitum. All rats had ad libitum access to water. All rats were maintained in temperature-controlled (23°C) facility with a 12-h light/dark cycle. Taking the cost of the labeled algae into consideration, the resultant 15 N labeled tissue usable as a quantitative internal standard is <$1/mg of protein.
Sample Preparation. Tissues were removed and stored as previously described. 23 Frozen tissues were homogenized in icecold homogenization buffer (4 mM HEPES, pH 7.4, 0.32 M sucrose) using 30 strokes in a tight-fitting Dounce homogenizer. Protein concentration was determined using the BCA protein assay (Pierce, Rockford, IL). One hundred micrograms of the 15 N tissue and the corresponding 14 N tissue were mixed. For example, 15 N labeled brain homogenate from a p1 pup was mixed with 14 N labeled brain homogenate from a p1 pup. The sample was then centrifuged at 14 000g for 15 min, and the superntant was discarded. One hundred twenty microliters of 5× Invitrosol (Invitrogen, Carlsbad, CA) containing 8 M urea was added to the pellet, and tris(2-carboxyethyl)-phosphine hydrochloride was added at a final concentration of 5 mM to reduce the proteins. This mixture was then vortexed for 1 h at room temperature. Next, iodoacetamide was added to a final concentration of 10 mM and was incubated in the dark at room temperature for 30 min to alkylate the sample. One hundred millimolar Tris, pH 8.0, 2 mM CaCl2 was added to the mixture to dilute the 5× Invitrosol to 1×. The mixture was divided into two equal aliquots, and 4 µg of trypsin (1 µg/µL) was added to each aliquot. The trypsin digestion was incubated at 37°C for 24 h. The digestion was stored at -80°C until mass spectrometry analysis.
Multidimensional Protein Identification Technology (Mud-PIT). MudPIT was performed as previously described using an LTQ linear ion trap mass spectrometer (ThermoFinnigan, San Jose, CA) and a quaternary high-performance liquid chromatography (HPLC) pump (Agilent, Foster City, CA) except for the following modification in the acquisition of the mass spectra. 24 A cycle of one full-scan mass spectrum (400-1400 m/z) followed by six data-dependent spectra was repeated continuously throughout each step of the multidimensional separation. The first data-dependent event was a zoom scan from the most intense peak to achieve high resolution of the isotope distribution. The second data-dependent event was an MS/MS scan of the most intense peak at a 35% normalized collision energy. The last four data-dependent events consisted of zoom scans and MS/MS scans for the second and third most intense peaks. All zoom scans were acquired using 25 microscans to improve signal to noise. Application of mass spectrometer scan functions and HPLC solvent gradients was controlled by the Xcalibur data system (ThermoFinnigan, San Jose, CA).
Analysis of Tandem Mass Spectra. Tandem mass spectra were analyzed using the following software analysis protocol. Poor-quality spectra were removed from the data set using an automated spectral quality assessment algorithm. 25 Tandem mass spectra remaining after filtering were searched with the SEQUEST algorithm version 27 26 against the EBI-IPI_rat_ 3.05_04-04-2005 database concatenated to a decoy database in which the sequence for each entry in the original database was reversed. 27 All searches were parallelized and were performed on a Beowulf computer cluster consisting of 100 1.2 GHz Athlon CPUs. 28 No enzyme specificity was considered for any search. SEQUEST results were assembled and filtered using the DTASelect (version 2.0) program. 29 DTASelect 2.0 uses a quadratic discriminant analysis to dynamically set XCorr and DeltaCN thresholds for the entire data set to achieve a userspecified false positive rate (5% in this analysis). The false positive rates are estimated by the program from the number and quality of spectral matches to the decoy database.
The percent atomic enrichment was estimated using a previously published procedure. 30 Briefly, the high-resolution zoom scans were employed to determine the 15 N peptide isotopic distributions, which are characteristic of the 15 N atomic percent enrichment of the peptide. The 15 N percent enrichment for a tissue was calculated from one MudPIT analysis of 100 µg of tissue. The spectra were searched for 14 N peptides, and an algorithm was used to find the corresponding 15 N peptide in the MS1 zoom scan. The algorithm predicts isotope distributions over a range of enrichments and compares the predicted distributions to experimental peptide isotope distributions. In addition, the algorithm generates a correlation factor between the matching 14 N and 15 N peptide with zero being no correlation and 1.0 being a perfect correlation. We used only 15 N peptides with a correlation factor greater than 0.7 to obtain the average 15 N enrichment for a given tissue. In addition, we determined that at least 100 15 N peptides are required to determined an accurate 15 N average percent enrichment of a tissue sample.
Statistical Analysis. We performed unpaired t-tests (twotailed) to determine significant differences between enrichment protocols. The sample size equaled the number of peptides for which we were able to determine a confident 15 N enrichment percentage (correlation value > 0.7). All statistical analyses were performed using Prism 4.0 software (GraphPad Software, San Diego, CA).
Results and Discussion
Enrichment Protocols. We designed two protocols for which rats were fed a 15 N enriched diet for two generations ( Figure  1 ). This diet was formulated by supplementing a protein-free Harlan rodent diet with 15 N enriched algal cells included as the sole protein source. Control rats were fed the same diet formulated with algae containing only natural abundance isotopes. In protocol 1, a pregnant rat was placed on the 15 N enriched diet on its second day of pregnancy (E2). This rat remained on the 15 N enriched diet after parturition and until it finished weaning its pups after 20 days. In protocol 2, a female rat was placed on the 15 N diet immediately after it was weaned. The rat remained on the diet during mating and pregnancy. For both protocols, the mother was sacrificed after it weaned its pups and the pups remained on the 15 N diet for an additional 25 days (Figure 1) .
We previously demonstrated that a rat on a 15 N diet lasting 44 days had no adverse physiological or histological consequences on a 3-week old rat. One potential concern, however, is the effect of 15 N labeling on fertilization, fetal development, gestation, or parturition. All the litters of rats on the 15 N diet were within the range of the average litter size for a rat, which is 7-11 pups (data obtained from Harlan, our rodent supplier) (Figure 2A) . In protocol 1, the mother was on the 15 N diet for 50 days while the mother from protocol 2 was on the 15 N diet for 107 days. Accordingly, we observed a lower enrichment of 15 N in tissues from mother1 (liver 86.0% ( 4.69; brain 71.9% ( 8.13) compared to mother2 (liver 94.4% ( 4.24; brain 83.3% ( 6.09) ( Figure 2B ). As might be expected, 15 N enrichment in the liver and brain increased with the longer labeling times and, consistent with our previous report, 20 the 15 N enrichment in the brain was lower than the enrichment in the liver in both protocols.
We analyzed the 15 N enrichment of tissues from the pups. We determined the enrichment levels of 15 N for the pups at p1 (postnatal day 1), p20, and p45. In liver, protocol 2 had an enrichment of 70.8% ( 6.48 and 88.8% ( 1.37 at p1 and p20, respectively. This is significantly higher 15 N enrichment compared to the liver in the p1 (66.3% ( 2.77) and p20 (76.6% ( 2.68) pups of protocol 1 ( Figure 3A) . This is likely due to the differences in the amount of 15 N labeled protein obtained while breast feeding. At p1 and p20, the sole source of protein for these pups had been breast milk from the mother, and the enrichment of 15 N in proteins was lower in the mother from protocol 1 (liver 86.0% ( 4.69; brain 71.9% ( 8.13) compared to the mother from protocol 2 (liver 94.4% ( 4.24; brain 83.3% ( 6.09) ( Figure 2B ). Since the enrichment in the pups cannot exceed their 15 N source, the pups from protocol 1 would be expected to have less 15 N enrichment than the pups from protocol 2. After weaning, however, the pups from both protocols were placed on the same diet enriched with 99% 15 N. After 25 days, the 15 N enrichment of pups from protocol 1 (96.2% ( 2.34) reached the level of the pups from protocol 2 (96.5% ( 5.07). These data suggest that 96% is the maximum 15 N labeled rats and the black bars represent litters from rats on the control diet. In protocol 1, one pregnant rat was placed on the 15 N diet and one pregnant rat on the control diet. In protocol 2, two female rats were placed on the 15 N diet and two on the control diet before mating. (B) The percent 15 N enrichment of liver and brain tissues from maternal rats. The black bars represent tissues from a maternal rat from protocol 1 and the white boxes represent tissues from a maternal rat from protocol 2. Values represent averages ( SD.
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tissue enrichment for two generations of rats on a diet consisting of 99% 15 N.
Determination of 15 N enrichment in the brain revealed that p1 (69.6% ( 4.08) and p20 (87.3% ( 2.40) pups of protocol 2 had significantly higher 15 N enrichment in proteins compared to the p1 (66.4% ( 2.27) and p20 (74.9% ( 2.34) pups of protocol 1 ( Figure 3B ). This is consistent with the observation from the liver. Furthermore, the 15 N enrichment of liver and brain is comparable in both protocols in the p1 and p20 pups. After approximately 40 days of metabolic labeling starting at fertilization, p20 pups in protocol 2 demonstrated a greater 15 N enrichment in brain tissue (>85%) compared to our previous attempt (74%) of labeling a 3-week old rat for 44 days. 20 Thus, beginning the labeling process earlier increases 15 N enrichment in the brain. This is consistent with reports demonstrating protein turnover in muscle tissue decreases with age. 31, 32 We did observe, however, a difference in 15 N enrichment between liver and brain in the p45 pups. In protocol 1, the 15 N brain enrichment was 87.0% ( 8.95 at p45, while in protocol 2, the 15 N brain enrichment was 95% ( 2.25 at p45, but in liver there was no significant difference between the 15 N enrichment of the two protocols at p45. Consistent with reported changes in mass spectra as the enrichment decreases, 30 the mass spectra of the same peptide from the p45 and p1 brain samples are quite different (Figure 4) . As a result, the signal-to-noise ratio will decrease, which causes two problems. First, identification of 15 N labeled peptides becomes difficult. Since the labeled and unlabeled protein samples are mixed 1:1, low enrichment will result in fewer proteins identified and then fewer proteins quantified. Second, low-signal intensity hinders the precision of extracting the ion chromatogram of the 15 N peptide, which leads to inaccurate quantification. Therefore, labeling for two generations is preferred to adequately enrich brain tissue The percent 15 N enrichment was determined for liver tissue at three developmental ages, p1, p20, and p45. There were significant differences (** p < 0.001) detected between the two enrichment protocols at p1 and p20, but no significant differences were detected at p45. (B) The percent 15 N enrichment was determined for brain tissue at three developmental ages, p1, p20, and p45. There were significant differences (** p < 0.001) detected between the two enrichment protocol at p1 and p20. In contrast to the liver tissue, there was a significant difference detected at p45 between the two enrichment protocols. Values represent averages ( SD. The peptide, K.EITALAPSTMK.I, was identified in both p45 (A) and p1 (B) brain samples from protocol 2. The peptide was measured to be 95% enriched in the p45 sample and 68% enriched in the p1 sample. The isotopic distribution of the 14 N peptide is identical in both mass spectra with the major peak at 1161.5 m/z, but the isotopic distribution for the 15 N peptide is different between the two samples. The major isotopic peak of the 15 N peptide in p45 is at 1173.5 m/z, while it is at 1170.5 m/z in p1. In addition, the 15 N isotopic distribution is broader and less intense in p1 compared to p45. The y-axis is relative abundance and the x-axis is mass/charge. with 15 N labeled proteins for high-accuracy quantitative measurements. Like brain tissue, muscle tissue also possesses a slow protein turnover rate. 22 In our previous report, skeletal muscle had the lowest 15 N enrichment (79%) of any tissue with the exception of brain tissue. 20 We analyzed skeletal muscle from our two protocols to determine if 15 N enrichment improves in muscle in addition to brain. Similar to the other tissues examined, the mother from protocol 2 (83.4% ( 5.04) had a higher 15 N enrichment in skeletal muscle compared to protocol 1 (72.9% ( 6.88) ( Figure 5A ). Furthermore, the p20 pups from protocol 2 (86.7% ( 2.59) had a higher 15 N enrichment in skeletal muscle compared to protocol 1 (76.1% ( 4.7) as expected. Similar to brain, there was a significant difference in 15 N enrichment in skeletal muscle between the two protocols (protocol 1 93.6% ( 2.37; protocol 2 95.9% ( 2.62) in p45 pups ( Figure 5B ). Thus, metabolic labeling of a rat for two generations produces a uniformly higher level of 15 N enrichment in all tissues known to have slow protein turnover.
Conclusions
We developed a metabolic labeling strategy to generate a rat with high levels of 15 N enrichment in proteins. The laboratory rat (Rattus norvegicus) is an extensively studied model organism for a range of aspects of human health and disease, physiology, toxicology, neurobiology, and drug development. For several human diseases, some clinical and molecular aspects are best studied in the rat, particularly neurodegenerative diseases and disorders affecting higher brain function, such as schizophrenia, anxiety, depression, and addiction. In addition, the mouse is another important disease animal model and initial experiments have demonstrated that this protocol is also applicable to this species. 33 Quantitative mass spectrometry has the potential to provide novel insight into these complex neurological disease models, and the ability to metabolically label rats with 15 N to a high degree of enrichment will allow more accurate and precise measurement of protein expression to better understand these diseases. We conclude here that labeling rats for two generations generates high 15 N enrichment of all tissues regardless of their intrinsic protein turnover rate. This SILAM strategy will be important in applying quantitative mass spectrometry to more complex systems such as tissues and organs with low protein turnover rates such as the brain.
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